BCL2 and mantle cell lymphoma: Primary resistance to venetoclax may be driven by the balance of BH3-only proteins, such as BCL-2-interacting mediator of cell death (BIM), and alternative BCL2 family proteins, such as MCL1 and BCL-XL, as observed in in vitro data from myeloma cell lines and patients with resistant mantle cell lymphoma[63].